FDA OKs Drug for Eosinophilic Granulomatosis With Polyangiitis FDA OKs Drug for Eosinophilic Granulomatosis With Polyangiitis

Mepolizumab is the first targeted drug for the rare eosinophil-driven disease formerly known as Churg-Strauss syndrome.FDA Approvals
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news